Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Soc Sci Med. 2016 Nov 9;172:153–162. doi: 10.1016/j.socscimed.2016.11.010

Table 2.

Characteristics of medications introduced during the study period. The number of prescriptions is the number of prescriptions written for the medication in the first 12 months after its introduction. Since we only observe Cymbalta from month four on, the total number of prescriptions is the number of scripts written between months four and twelve.

Name Class Introduced Prescriptions Therapeutic Improvement
Cymbalta Antidepressant 8/2004 1,313,938 Indication for pain and Fibromyalgia.
Vyvanse Stimulant 3/2007 1,195,185 Less potential for abuse. Longer acting.
Invega Antipsychotic 12/2006 170,623 Little or no improvement.
Pristiq Antidepressant 2/2008 573,298 Little or no improvement.